SCHEMBL6489300

SCHEMBL6489300

[CH2]c1c(CC)nn2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 3/20 0.38
DRD3 P35462 3/20 0.38
DRD2 P14416 2/20 0.38
HDAC1 Q13547 2/20 0.37
MIF P14174 2/20 0.36
ALDH1A1 P00352 3/20 0.36
PDE5A O76074 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE3A Q14432 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
PDE4A P27815 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6480217 0.82 EGFR (0.35) DRD4DRD3DRD2MIFALDH1A1
SCHEMBL23382438 0.80 HDAC1 (0.46) DRD4DRD3DRD2HDAC1MIF
SCHEMBL6489306 0.80 DRD2 (0.39) DRD4DRD3DRD2HDAC1MIF
SCHEMBL5847660 0.79 EGFR (0.41) DRD4DRD3DRD2HDAC1MIF
SCHEMBL2012799 0.79 DRD4 (0.38) DRD4DRD3DRD2HDAC1MIF
Hydrochloric Acid SCHEMBL38663344 0.77 EGFR (0.41) DRD4DRD3DRD2HDAC1MIF
SCHEMBL1780171 0.76 HDAC1 (0.46) DRD4DRD3DRD2HDAC1MIF
SCHEMBL23382439 0.76 MIF (0.43) DRD4DRD3DRD2HDAC1MIF
SCHEMBL24415150 0.76 HDAC1 (0.38) DRD4DRD3DRD2HDAC1MIF
SCHEMBL5847384 0.76 MIF (0.41) DRD4DRD3DRD2HDAC1MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed
EP-1373199-A4 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-04-07 EP disclosed
EP-1373199-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) Bristol-Myers Squibb Pharma Company (US) 2004-01-02 EP disclosed
WO-2002074738-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-26 WO disclosed